Nystatin And Triamcinolone Acetonide
Nystatin + Triamcinolone Acetonide
10 active makers
soon
soon
soon
soon
US acquisition costNADAC · per unit
Average across 11 priced NDCs. A benchmark of pharmacy acquisition cost - not a retail quote.
Nystatin + Triamcinolone Acetonide
Average across 11 priced NDCs. A benchmark of pharmacy acquisition cost - not a retail quote.
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume - Medicaid only, not all-payer.
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Alembic Pharmaceuticals Limited | generic | 6 | SUPPLYING |
| Preferred Pharmaceuticals Inc. | repackager | 4 | SUPPLYING |
| Torrent Pharmaceuticals Limited | unknown | 3 | SUPPLYING |
| Crown Laboratories | unknown | 3 | SUPPLYING |
| Macleods Pharmaceuticals Limited | generic | 3 | SUPPLYING |
| SUN PHARMACEUTICAL INDUSTRIES, INC. | generic | 3 | SUPPLYING |
| Glenmark Pharmaceuticals Inc., USA | generic | 3 | SUPPLYING |
| Lupin Pharmaceuticals,Inc. | generic | 2 | SUPPLYING |
| NuCare Pharmaceuticals,Inc. | repackager | 2 | SUPPLYING |
| REMEDYREPACK INC. | repackager | 1 | SUPPLYING |
Shortages, recalls, and registration changes attached to this drug concept.
Failed Content Uniformity Specifications: Out-of-specification result observed in uniformity of containers test at 9 month long term stability condition for upright orientation. — Recalling firm: Lupin Pharmaceuticals Inc. — Nationwide within the United States
Failed Content Uniformity Specifications; out-of-specification (OOS) results 18-month stability — Recalling firm: Taro Pharmaceuticals U.S.A., Inc. — Nationwide and Puerto Rico